Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
Jasper Therapeutics (JSPR) Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS
-
General Atomics Brings Inertial Fusion Energy Expertise to Two National Research Hubs
-
Atlantic Union Bankshares (AUB) Names Three New Board Members
-
Analog Devices (ADI) Appoints Peter Henry to its Board of Directors
-
ADP Employment Change 103K vs 130K Expected
-
Stryker (SYK) announces Dr. Srikant Datar will retire from Board of Directors
-
Truist Securities Starts Cargo Therapeutics (CRGX) at Buy, 'Packing A Bigger Punch In To CAR-T'
-
JPMorgan Starts Cargo Therapeutics (CRGX) at Overweight
-
Viracta Therapeutics (VIRX) Announces Interim Data from Phase 1b/2 Clinical Trial of Nana-val in Patients with Epstein-Barr Virus-Positive Solid Tumors that Show Confirmed Tumor Responses at Higher Do
-
Gossamer Bio (GOSS) Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors
-
Babcock & Wilcox (BW) Appoints Naomi Boness to its Board
-
Q2 Holdings (QTWO) Appoints Himagiri Mukkamala as Chief Development Officer, Beth-Anne Bygum as Chief Information Security Officer, Blair Williams as Chief Risk Officer
-
IO Biotech (IOBT) Appoints Helen Collins to its Board
-
STANFORD STUDENT SELECTED TO COMPETE IN THE 2024 OLYMPIC TRIALS FOR BOXING
-
CyberArk Software (CYBR) Appoints Mary Yang to its Board
-
Pasithea Therapeutics (KTTA) Selects PAS-003 Lead Development Candidate, a Humanized Monoclonal Antibody that Targets α5β1 Integrin for the Treatment of both Sporadic and Familial ALS
-
STANFORD ONLINE HIGH SCHOOL LAUNCHES ADVANCED, IMMERSIVE ONLINE MATH COURSE THROUGH UNIVERSITY-LEVEL ONLINE
-
Stanford to use Sequentify kits for Hematological Malignancies NGS Sequencing
-
Assembly Biosciences (ASMB) Appoints Anuj Gaggar as Chief Medical Officer
-
Bernhard Capital-Backed Grace Hebert Curtis Acquires HAHNFELD HOFFER STANFORD ARCHITECTS
-
Alpine Immune Sciences (ALPN) Presents New Preclinical Data on Povetacicept in Myasthenia Gravis
-
Kratos Defense (KTOS) Announces Board Changes
-
F5 Networks (FFIV) Appoints Tami Erwin to its Board
-
Alpine Immune Sciences (ALPN) Presents Initial Clinical Data on Povetacicept in Autoimmune Glomerulonephritis in a Late-Breaking Poster Session
-
Fiverr International (FVRR) Appoints Matti Yahav as Chief Marketing Officer
-
Walgreens Boots Alliance (WBA) Appoints Neal Sample as EVP and Chief Information Officer
-
ADP Employment Change 113K vs 150K Expected
-
Ultima Genomics to Present at ASHG and Provide Updated Reference Data Set
-
Protagonist Therapeutics (PTGX) Appoints Daniel Swisher to its Board
-
Stanford Study Finds Lung Cancer Cells Hide, Thrive in the Brain
-
Immix Biopharma (IMMX) Appoints Michaela Liedtke to its Scientific Advisory Board
-
CARGO Therapeutics (CRGX) Announces Proposed IPO
-
Avadel Pharma (AVDL) Announces Data Supporting Clinical Profile for LUMRYZ for extended-release oral suspension at World Sleep 2023
-
Stanford researchers issue AI transparency report, urge tech companies to reveal more
-
Ardelyx (ARDX) Announces FDA Approval of XPHOZAH
-
OneMedNet (DKDCA) Announces Board of Directors for Post-Merger Company
-
Beyond Air (XAIR) Publishes Pre-Clinical Data in Cells Demonstrating that the Combination of Ultra-High Concentration Nitric Oxide and Anti-mPD-1 Therapy Improves Tumor Regression Rates and Survival i
-
Merck (MRK) Announces FDA Approval of KEYTRUDA for Treatment of Patients With Resectable NSCLC in Combination With Chemotherapy
-
Caterpillar (CAT) Appoints Joseph E. Creed as COO
-
Allogene Therapeutics (ALLO) Appoints Geoffrey Parker as Chief Financial Officer
-
Fusion Pharmaceuticals (FUSN) Appoints Jeremy Bender, Teresa Bitetti and David Meek to its Board
-
Beyond Air (XAIR) Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide in Combination with Checkpoint Inhibitor Therapy
-
Bentley Systems (BSY) Announces Executive Appointments
-
Poseida Therapeutics (PSTX) Announces Leadership Transition
-
Anebulo Pharmaceuticals (ANEB) Appoints Bimal Shah to its Board
-
Repro Med Systems (KRMD) Appoints Edward Wholihan to Its Board
-
ADP National Employment Report: Private Sector Added 89,000 Jobs in September; Annual Pay Up 5.9%
-
Eli Lilly & Co. (LLY) Announces Retirement of Mike Mason, President of Lilly Diabetes and Obesity
-
Larimar Therapeutics (LRMR) Appoints Jeffery W. Sherman to its Board
-
Bright Green (BGXX) Appoints Groovy Singh as CEO

